About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

2-Drug Combo Retards Advanced Pancreatic Cancer: Mayo Clinic-Led Study

by Nancy Needhima on April 4, 2012 at 1:05 PM
Font : A-A+

2-Drug Combo Retards Advanced Pancreatic Cancer: Mayo Clinic-Led Study

Combining novel drug TH-302 with the standard drug gemcitabine reveals early signs of delaying the worsening of cancer in patients with advanced pancreatic cancer discovered a Mayo Clinic-led study. This was evaluated using a measure termed progression-free survival (PFS). According to the results of a multi-center Phase II clinical trial, patients receiving the combination of gemcitabine and TH-302 demonstrated a progression-free survival of 5.6 months compared to 3.6 months in those patients who received gemcitabine alone.

The two-month delay in worsening of the cancer is considered significant given that the average survival of patients with advanced pancreatic cancer is only six to seven months.

Advertisement

Lead researcher Mitesh Borad, M.D., of Mayo Clinic in Arizona, will present the results of the Phase II study on Monday, April 2, at the American Association for Cancer Research (AACR) Annual Meeting.

The scientific basis of using TH-302 is to target low-oxygen (hypoxic) areas in cancers that are a common source of drug resistance to conventional chemotherapy drugs. Promising results of the combination of TH-302 and gemcitabine in pancreatic cancer animal models preceded this clinical trial in patients.
Advertisement

The Phase II clinical trial included 214 patients from June 2010 to June 2011 at 45 centers. Patients were randomized to receive standard therapy with gemcitabine or gemcitabine in combination with one of two doses of TH-302.

"The results of the trial support ongoing study of TH-302 in pancreatic cancer," Dr. Borad says.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Pancreatic Cancer Pancreatitis Pancreas Transplantation 

Recommended Reading
FOLFIRINOX- Drug Combination Prolongs Survival in Pancreatic Cancer Patients
A new drug chemotherapy combination of FOLFIRINOX may boost survival of pancreatic cancer ......
Potent Biomarker for Pancreatic Cancer Identified
Survivin protein serves as a useful tool in understanding pancreatic cancer, say scientists....
Research Sheds Light on Metastasis of Pancreatic Cancer
Pancreatic cancer cells in an animal model begin to spread before clinically obvious tumor tissue .....
Pancreas Transplantation
Pancreas transplant is a surgical procedure involving the replacement of a dysfunctional pancreas in...
Pancreatic Cancer
Pancreatic cancer often involves its exocrine part. It grows aggressively, and often detected late. ...
Pancreatitis
Pancreatitis or inflammation of the pancreas may show up as acute pancreatitis or chronic pain. Alco...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use